CTN Dissemination Library

  • Browse & Search
    • Search the CTN Library
    • In press articles
    • Search the site/blog
  • Nodes
  • Protocols
  • Training
    • CTN & Other Training
    • Upcoming Events
  • Resources
    • What’s New Blog
    • NIDA CTN Site
    • CTN Bulletin
    • CTN Common Data Elements (CDE)
    • CTN Directory (2025)
    • PATHS Toolkit
    • Implementation
    • General Resources
  • About Us
  • Browse & Search
    • Search the CTN Library
    • In press articles
    • Search the site/blog
  • Nodes
  • Protocols
  • Training
    • CTN & Other Training
    • Upcoming Events
  • Resources
    • What’s New Blog
    • NIDA CTN Site
    • CTN Bulletin
    • CTN Common Data Elements (CDE)
    • CTN Directory (2025)
    • PATHS Toolkit
    • Implementation
    • General Resources
  • About Us
  • Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment.

    Smith CL, McPherson SM, Rodin N, Hovland SE, Akana N, Miguel AQC, Marsden J, Saxon AJ. Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment. Drug and Alcohol Dependence 2026;278:112993.

    Read More
  • A clinical trial loses access to some of its experimental treatment conditions: What can be done? [commentary]

    Meyers-Ohki S, Shulman M, Weiss RD, Novo P, Provost S, Otterstatter M, Bailey GL, Rotrosen J, Nunes EV. A clinical trial loses access to some of its experimental treatment conditions: What can be done? Journal of Substance Use and Addiction Treatment 2025: 209854 (in press).

    Read More
  • Gender-specific addiction research needed now more than ever: Reflections from 25 years of the NIDA Clinical Trials Network Gender Special Interest Group.

    Campbell ANC, Burlew AK, Guille C, Haidamus MA, Hien DA, Lofwall MR, Paschen-Wolff MM, Patten CA, Sugarman DE; Winhusen TJ, Bakhireva LN, Loree AM, Mazel S, Greenfield SF. Gender-specific addiction research needed now more than ever: Reflections from 25 years of the NIDA Clinical Trials Network Gender Special Interest Group. Journal of Substance Use and Addiction Treatment 2025: 209849 (in press).

    Read More
  • Future pandemic preparedness: conceptualizing vaccine willingness in drug-using populations during COVID-19 in Southeastern U.S. cities.

    Orozco K, Laschober TC, Tross S, Ertl MM, Paschen-Wolff MM, Nelson CM, Lancaster C, Hatch MA. Future pandemic preparedness: conceptualizing vaccine willingness in drug-using populations during COVID-19 in Southeastern U.S. cities. Journal of HIV/AIDS & Social Services 2025 (in press).

    Read More
  • Predicting willingness to use MOUD: An application of the theory of reasoned action and theory of planned-behavior.

    Lancaster C, Laschober TC, Nelson CM, Hatch MA, Paschen-Wolff MM, Ertl MM, Wright L, Tross S. Predicting willingness to use MOUD: An application of the theory of reasoned action and theory of planned-behavior. Journal of Drug Issues 2025 (in press).

    Read More
  • Overdose risk profiles in pregnancy: Latent class analysis of pregnant individuals with opioid use disorder.

    Cash E, Cochran G, Smid MC, Charles JE, Humiston G, Wei Y, Mauerman N, Carlston K, Broussard G, Sengpraseut B, Martin PR, Winhusen TJ. Overdose risk profiles in pregnancy: Latent class analysis of pregnant individuals with opioid use disorder. Journal of Substance Use and Addiction Treatment 2025 (in press).

    Read More
  • Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysis.

    Lofwall MR, Kropp F, Charles J, Cochran G, Douaihy A, Edwards M, Lewis D, Rosa C, Young JL, Winhusen TJ. Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysis. Journal of Substance Use and Addiction Treatment 2025 (in press).

    Read More
  • Buprenorphine treatment for opioid use disorder in non–addiction specialty settings.

    Huebler S, Jones AL, Zhao H, Nelson RE, Hagedorn HJ, Hawkins EJ, Gordon AJ. Buprenorphine treatment for opioid use disorder in non–addiction specialty settings. JAMA Network Open 2025;8(11):e2543543.

    Read More
  • Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone.

    Rudolph KE, Inose S, Williams NT, Díaz I, Ross RK, Bisaga A, Shulman M. Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone. Addiction 2025;121(1):117-125.

    Read More
  • Integrating x-waiver training for opioid use disorder into the nurse practitioner and physician assistance curricula.

    Moreland AD, Durham CO, Rafferty A, Hartwell KJ. Integrating x-waiver training for opioid use disorder into the nurse practitioner and physician assistance curricula. Journal of the American Association of Nurse Practitioners 2025;37(7):406-412.

    Read More
12345

Recent Posts

  • Now in the CTN Library: NIDA CTN Common Data Elements
  • New in the Library (March – April 2026)
  • CTN Primary Care SIG Webinar: Conducting Substance Use Research in Prison (March 23, 2026, 12pm ET)
  • New in the Library (February – March 2026)
  • News from the Appalachian Node: Brief Report for CTN-0135 Published

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • September 2022

Categories

  • DSC News
  • Events
  • Funding
  • Jobs
  • New in the Library
  • Node News
  • Other
  • Protocol News
  • SIG Updates
  • Uncategorized
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Department of Psychiatry & Behavioral Science's Addictions, Drug & Alcohol Institute (ADAI). The materials on this site have neither been created nor reviewed by NIDA.